Fovea SA was acquired by Sanofi in Oct. 2009 for up to €370 million. Fovea was created in 2005 by Professor Jose A. Sahel, Bernard Gilly and Pierre Belichard, with the initial seeding of Sofinnova Partners in Paris.

Biopharmaceuticals